Showing 1 - 10 of 91
On 10 September 2021 the government published a consultation on reforms to data protection law in the UK. Data: A new direction (the Consultation) proposes wholesale change to the UK legal framework, including the UK General Data Protection Regulation (UK GDPR). The changes, if implemented, are wide-ranging and significant and reinforce the government’s aim to capitalise on the UK’s “independent status” and create an ambitious, pro-growth and innovation-friendly data protection regime that maintains its high protection standards.
Recently, there have been considerable developments in respect of the EU’s product safety regulatory regime for pharmaceuticals, reflected in a recent consultation on key EU legislation on pharmacovigilance and a report produced by the European Commission on the efficacy of an EU regulation that controls the sale and safety monitoring of medicines.
We are delighted to have appointed one of the country’s leading data specialists as part of a bold new strategy which will revolutionise the way we does business.
Kennedys is recognised as a top-band firm in the latest guide to leading law firms and lawyers across the UK.
Following the publication of The Legal 500 UK 2022, we are proud to announce that the firm has once again achieved impressive rankings and recognition within the latest guide to leading law firms and lawyers.
We are pleased to have strengthened our London team with the appointment of partner Simon Durkin, formerly at Weightmans.
We are pleased to again report a record turnover of £264m, an increase of 11% on the previous year (£238m).We have also increased the number of fee earners globally by 10%, taking the firm’s overall headcount to in excess of 2,300
Regulatory compliance in unprecedented times: how to adapt but stay on track - a guide for the European life sciences industry
The COVID-19 pandemic has had an unprecedented impact on stakeholders in the UK and EU’s life sciences industry - from companies, to third parties, governments, regulators and insurers.
We are pleased to announce that the publication of the 2021 edition of The Legal 500 Europe, Middle East and Africa has seen us build on our 2020 achievements.
In this Q&A, Ian Kimber, Emeritus Professor of Toxicology in the Faculty of Biology, Medicine and Health at the University of Manchester, provides an immunological perspective on current issues impacting upon the life sciences sector, ranging from recently approved cancer drugs to COVID-19 vaccines.